Table 3: Summary of pooled hazard ratios for overall survival according to molecular biomarkers (HR <1 indicates improved survival, whereas HR >1 indicates poorer survival).
|
Molecular Marker |
No. of Studies |
Patients (n) |
HR |
95% CI |
p-value |
I² (%) |
|
IDH Mutation |
24 |
8,934 |
0.59 |
0.48-0.72 |
<0.001 |
32.2 |
|
1p/19q Codeletion |
18 |
6,521 |
0.38 |
0.28-0.52 |
<0.001 |
27.4 |
|
CDKN2A/B Deletion |
11 |
3,912 |
1.82 |
1.44-2.31 |
<0.001 |
35.1 |
|
TERT Promoter Mutation |
13 |
4,801 |
1.41 |
1.12-1.79 |
0.003 |
41.8 |
|
EGFR Amplification |
9 |
3,455 |
1.65 |
1.26-2.17 |
<0.001 |
38.5 |
|
+7/−10 Signature |
7 |
2,611 |
1.72 |
1.29-2.30 |
<0.001 |
30.4 |